Shilpa Medicare Ltd's finished dosage form manufacturing facility, Unit IV, situated at Pharma SEZ, Jadcherla, Telangana has received Health Canada GMP approval
South Asia’s largest exhibition for pharma brought together over 50,000 visitors from across the globe
The company sees the business reaching $100mn
The company has received the Certificate of GMP Compliance from the representative European inspection authority, Health Products Regulatory Authority (HPRA), Ireland.
The new plant will include a wide range of dosage form capabilities for oral solids, liquids, topicals, films, and manufacturing technologies for granulation, film coating, spray drying, tableting
New material distribution will serve medical device and pharmaceutical packaging manufacturers.
The ninth acquisition since 2018
The approved product has an estimated market size of around US $62 million for the twelve months ending June 2022 according to IQVIA
Ministry of Ayush signed a MoU with Ministry of Micro, Small & Medium Enterprises (MSME) for the promotion of Ayush enterprises.
ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.
Subscribe To Our Newsletter & Stay Updated
